Bladder Cancer Trial, Recruiting NCT07524426 Sponsor: Umeå University Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT07524426
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to give consent to take part, both verbally and in writing
  • People who have been diagnosed with muscle-invasive bladder cancer that has been confirmed through laboratory testing of tissue, and whose cancer includes a specific cell type called urothelial
  • People aged 18 years or older, of any gender
  • People whose medical team, after a group review meeting, has determined that curative (aimed at curing) treatment is unlikely to benefit them, or who have personally chosen not to pursue curative treatment

Who may not be able to join:

  • People who score 8 or higher on a scale used to measure frailty (physical vulnerability in older adults) — confirm with trial site for details on how this is assessed
  • People who have previously had radiation therapy to the pelvic area in a way that would significantly overlap with the treatment area for this trial
  • People whose scans show the cancer has spread to internal organs or bones
  • People whose scans show the cancer has spread to more than 3 lymph nodes, with at least one of those measuring larger than 2 cm
  • People who are already planned to receive systemic treatment (such as chemotherapy or immunotherapy given throughout the body) at the time of joining the trial
  • People who have already been recommended for radiation therapy to the bladder to relieve symptoms at the time of joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Umeå University
Registry
ClinicalTrials.gov
Start date
3 June 2026
Est. completion
1 June 2032

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Overall Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov